Axogen director sells shares after option exercise
Axogen, Inc. director Wendell Amy McBride exercised stock options and sold the resulting shares.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Axogen, Inc. director Wendell Amy McBride exercised stock options and sold the resulting shares. On May 8, 2026, she exercised options covering 1,647 shares of common stock at $14.85 per share, then completed an open-market sale of 1,647 shares at a weighted average price of $42.60 per share, with individual sale prices ranging from $42.50 to $42.62. After these transactions, she directly held 93,826 shares of Axogen common stock.
Insider Trade Summary
Exercise and Sale: 1,647 shares ($46K approx. pre-tax spread)
Exercise and Sale
3 txns
Insider
Wendell Amy McBride
Role
Director
Sold
1,647 shs ($70K)
Approx. gross sale proceeds
$70K
Approx. exercise cost
$24K
Approx. pre-tax spread
$46K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (right to purchase) | 1,647 | $0.00 | $0.00 |
| Exercise | Common Stock | 1,647 | $14.85 | $24K |
| Sale | Common Stock | 1,647 | $42.60 | $70K |
Holdings After Transaction:
Employee Stock Option (right to purchase) — 13,353 contracts (Direct);
Common Stock — 93,826 shares (Direct)
Footnotes (2)
- F1. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $42.50 to $42.62 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- F2. All shares of Axogen, Inc. common stock underlying the board of director's stock option were fully vested on May 31, 2018.
Key Figures
Shares sold: 1,647 shares
Sale price: $42.60 per share
Shares exercised: 1,647 shares
+4 more
7 metrics
Shares sold
1,647 shares
Open-market sale of common stock on May 8, 2026
Sale price
$42.60 per share
Weighted average sale price; trades from $42.50 to $42.62
Shares exercised
1,647 shares
Common stock acquired via option exercise on May 8, 2026
Option exercise price
$14.85 per share
Exercise price of employee stock option
Shares held after transaction
93,826 shares
Total Axogen common stock directly owned after transactions
Option underlying shares
1,647 shares
Underlying common shares for exercised employee stock option
Option expiration date
June 1, 2027
Expiration of Employee Stock Option (right to purchase)
Key Terms
open-market sale, weighted average sale price, Employee Stock Option (right to purchase), derivative security, +1 more
5 terms
open-market sale financial
"transaction_action is described as an open-market sale of common stock"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
weighted average sale price financial
"The reported price is a weighted average sale price for multiple trades"
Employee Stock Option (right to purchase) financial
"Security title is Employee Stock Option (right to purchase) underlying common stock"
derivative security financial
"The Form 4 describes the option transaction as an exercise of a derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
underlying security financial
"The option lists Axogen common stock as the underlying security shares"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Axogen (AXGN) director Wendell Amy McBride report?
Wendell Amy McBride reported exercising stock options for 1,647 Axogen shares and selling 1,647 shares in an open-market transaction. Both the option exercise and sale occurred on May 8, 2026, and involved Axogen common stock.
What was the option exercise price in the Axogen (AXGN) Form 4 filing?
The reported employee stock options were exercised at $14.85 per share for 1,647 underlying Axogen common shares. This exercise price reflects the strike price of the option, not the market price at which the shares were later sold.
What derivative security was involved in the Axogen (AXGN) director’s transaction?
The transaction involved an Employee Stock Option (right to purchase) with a conversion price of $14.85 per share for 1,647 underlying common shares. The options were fully vested and had an expiration date of June 1, 2027.
AI-generated analysis. How Rhea-AI works. Not financial advice.
